High impact
Oxaliplatin (CPB 0683, reviewed 2025-12-05)
Aetna·Effective Dec 5, 2025
CPT 96425, in plain terms, covers Delivering cancer-fighting drugs directly into the bloodstream through an IV line over a set period of time. CPT 96425 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 96425 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Official descriptor: CPT 96425 on AAPC
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.